Global Viral Vector CDMO Market to Hit $5.8 Billion by 2034 as CAGR Nears 19%

1 articles · Updated · Yahoo Finance · Aug 18

$5.8 billion is the projected size of the global viral vector CDMO market by 2034, up from $1.1 billion in 2025, according to DelveInsight.
Nearly 19% annual growth is being driven by expanding gene and cell therapy development, a rising number of clinical trials, and stronger demand for scalable, high-quality viral vector manufacturing.
Biopharmaceutical companies are increasingly turning to specialized CDMOs to speed development and commercialization, while investment in capacity, production technology and compliant facilities supports that expansion.
North America is the largest regional market, AAV is the leading vector segment, and continued advanced-therapy approvals plus a deep gene-treatment pipeline are expected to sustain longer-term growth.